top of page

Innovations in ODN and EV Technologies

Discover VLPtech’s cutting-edge innovations in Oligonucleotide (ODN) and Extracellular Vesicle (EV) technologies. From immunotherapy to precision diagnostics, learn how we're shaping the future of medicine.

Untitled (1).png
main-background

Our Immunostimulatory ODN Technologies

  • Infectious Diseases: We develop universal prophylactic agents using ODNs to protect against pathogens for which no vaccines are available.

  • Cancer Immunotherapy: Our ODNs are used to eradicate cancer either as standalone treatments or in combination with other therapies.

  • Vaccine Adjuvant: We enhance vaccines by incorporating ODNs to improve the efficacy and protective capacity of antigens.

  • Allergy: In allergen immunotherapy, our ODNs shift the immune response from Th2-biased to Th1-biased immunity, reducing eosinophilia and allergic symptoms.

Our Immunosuppressive ODN Technologies

  • General Information: Our suppressive ODNs downregulate excessive immune reactions, reducing flares in autoimmune and autoinflammatory conditions.

  • Mechanism of Action: Our ODNs inhibit key pathways including TLR signaling, STAT phosphorylation, mTOR pathway, Inflammasome pathway, and cytosolic DNA sensors.

  • Target Diseases: Our technology is applied to a variety of diseases, including Rheumatoid Arthritis, SLE, Sjogren’s Disease, and more, improving outcomes in conditions ranging from fibrosis to sepsis.

Our EV Technologies

  • Therapy: We create personalized therapeutic cancer vaccines using EVs as sources of antigens. By isolating EVs from biopsies or plasma, loading them with immunostimulatory ligands, and reintroducing them to the patient, we can effectively regress established tumors.

  • Disease Diagnostics: Our diagnostic approach includes isolating specific EVs to identify biomarkers for diseases like prostate cancer and Behcet's disease, as well as signature molecules for conditions such as Nephrotic Syndrome. These biomarkers are crucial for designing effective therapies and managing disease progression.

Explore the potential of VLPtech's pioneering technologies. Join us as we continue to innovate and transform the landscape of medical treatment and diagnostics.

main-background
main-background

Let's Chat

Address

VLP Technology Vaccine and Drug Inc.

Mustafa Kemal Mah. Dumlupınar Bul. No 280 G İç Kapı No 1260 Çankaya, Ankara, Türkiye

Email

Thanks for submitting!

bottom of page